JAK1 Inhibitor Filgotinib Shows Efficacy in Treatment of Psoriatic Arthritis
Gilead and Galapagos NV announced the results of two phase 2 human trials evaluating filgotinib in adults with psoriatic arthritis.
Jounce Regains Worldwide Rights to LILRB2 Inhibitor JTX-8064 from BMS
Rights to the antibody candidate JTX-8064 have been transferred from Bristol-Myers Squibb back to Jounce Therapeutics effective June 3rd 2020.
MDSC Metabolite Found to Underly Immunosuppression, May Aid Cancer Therapy
TUM researchers have found that methylglyoxal underlies MDSC-mediated immunosuppression with implications for cancer diagnosis and treatment.
CAR-T Therapy Yescarta Leads to High Response Rate in Non-Hodgkin Lymphoma
Interim analysis of the ZUMA-5 trial found that Yescarta showed efficacy for treating relapsed or refractory indolent non-hodgkin lymphoma.
Addiction-Treating Drug Also Prevents Inflammation, Researchers Find
Disulfiram, a drug approved by the FDA for treating alcohol addiction, has been found to antagonize inflammation and could treat key diseases .
Altered Function of Aging CD8+ T Cells Linked to Stress-Sensing Sestrins
Research by Dr. Arne Akbar and colleagues has shown that NK cell-like behavior of aging CD8+ T cells is linked to the expression of sestrins.
The 5 Best Immunology Textbooks of 2020
Whether you are a medical or PhD student, physician, scientist, or undergraduate, these immunology textbooks are likely to support your goals.
Altimmune To Initiate Phase 1/2 Clinical Trial of COVID-19 Therapy T-COVID
T-COVID is anticipated to provide clinical benefit to COVID-19 patients that are not yet hospitalized in the phase 1/2 clinical trial.
Top 10 Immunology Journals of 2020
Here are the top 10 scientific journals in the field of Immunology ranked according to the h-5 index of Google and SCImago ranking system.
Novavax Expands Vaccine Manufacturing Capacity by Acquiring Praha Vaccines in the Czech Republic
Novavax has purchased Praha Vaccines, a biologics manufacturer in the Czech Republic, to support mass production of its COVID-19 vaccine.